Xiaoyi Chong

机构：Peking University, Peking University Cancer Hospital

发表论文 36 篇 · 总被引 523 次 · h-index 12

代表论文

• Recent developments in immunotherapy for gastrointestinal tract cancers (2024 · Journal of Hematology & Oncology · 被引 115)
• Associations of subcutaneous fat area and Systemic Immune-inflammation Index with survival in patients with advanced gastric cancer receiving dual PD-1 and HER2 blockade (2023 · Journal for ImmunoTherapy of Cancer · 被引 58)
• ANO1‐Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer‐Associated Fibroblasts (2023 · Advanced Science · 被引 52)
• Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study (2024 · Chinese Journal of Cancer Research · 被引 37)
• Implications of PD-L1 expression on the immune microenvironment in HER2-positive gastric cancer (2024 · Molecular Cancer · 被引 34)
• Multidimensional immune profiling in Gastric Cancer Multiplex Immunohistochemistry Atlas from Peking University Cancer Hospital project informs PD-1/PD-L1 blockade efficacy (2023 · European Journal of Cancer · 被引 16)